Sensex Rises Over 250 Points, Nifty Above 16,300; IT, Pharma Stocks Surge
Indian equity benchmarks on Wednesday rose in opening deals led by gains in information technology and pharma stocks.
Asian shares struggled to carry recent gains into a fourth straight session today. Overnight, Wall Street indexes had jumped and the U.S. dollar recoiled from near two-decade highs.
Back home, the 30-share BSE Sensex jumped 256 points or 0.47 per cent to 54,574, while the broader NSE Nifty moved 79 points or 0.49 per cent up to trade at 16,339.
Mid- and small-cap shares were trading on a strong note as Nifty Midcap 100 gained 0.59 per cent and small-cap climbed 0.52 per cent.
13 out of the 15 sector gauges -- compiled by the National Stock Exchange -- were trading in the green. Nifty IT and Nifty Pharma were outperforming the index by rising as much as 1.11 per cent and 1.01 per cent, respectively.
On the stock-specific front, Tech Mahindra was the top gainer as the stock soared 1.74 per cent to Rs 1,219. Axis Bank, Bajaj Finance, Tata Consumer Products and Shree Cement were also among the gainers.
The overall market breadth stood strong as 1,964 shares were advancing while 558 were declining on BSE.
On the 30-share BSE index, TechM, Axis Bank, Bajaj Finance, UltraTech Cement, Wipro, Infosys, Sun Pharma, HDFC Bank, Dr Reddy's and TCS were among the top gainers.
Meanwhile, shares of Life Insurance Corporation of India (LIC) were up 1.29 per cent at 886.70 against its previous close of Rs 875.45. LIC made a tepid debut at the stock exchanges yesterday, listing at a discount of 8.62 per cent.
In contrast, PowerGrid, NTPC and Tata Steel were trading in the red.
Sensex had rallied 1,345 points or 2.54 per cent to close at 54,318 on Tuesday, while Nifty had moved 417 points or 2.63 per cent up to settle at 16,259.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.